The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL

Eisenstein, 2000, Iron regulatory proteins and the molecular control of mammalian iron metabolism, Annu. Rev. Nutr., 20, 627, 10.1146/annurev.nutr.20.1.627 Cairo, 2000, Iron regulatory proteins in pathobiology, Biochem. J., 352, 241, 10.1042/0264-6021:3520241 LaVaute, 2001, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nat. Genet., 27, 209, 10.1038/84859 Guo, 1995, Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome, J. Biol. Chem., 270, 21645, 10.1074/jbc.270.37.21645 Hanson, 1999, Hypoxia post-translationally activates iron-regulatory protein 2, J. Biol. Chem., 274, 5047, 10.1074/jbc.274.8.5047 Iwai, 1995, Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2, EMBO J., 14, 5350, 10.1002/j.1460-2075.1995.tb00219.x Iwai, 1998, Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins, Proc. Natl. Acad. Sci. U. S. A., 95, 4924, 10.1073/pnas.95.9.4924 Wang, 2004, Iron-mediated degradation of IRP2: an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity, Mol. Cell. Biol., 24, 954, 10.1128/MCB.24.3.954-965.2004 Hanson, 2003, Oxygen and iron regulation of iron regulatory protein 2, J. Biol. Chem., 278, 40337, 10.1074/jbc.M302798200 Tanimoto, 2000, Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel–Lindau tumor suppressor protein, EMBO J., 19, 4298, 10.1093/emboj/19.16.4298 Guillemin, 1997, The hypoxic response: huffing and HIFing, Cell, 89, 9, 10.1016/S0092-8674(00)80176-2 Semenza, 1998, Hypoxia-inducible factor 1: master regulator of O2 homeostasis, Curr. Opin. Genet. Dev., 8, 588, 10.1016/S0959-437X(98)80016-6 Masson, 2001, Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation, EMBO J., 20, 5197, 10.1093/emboj/20.18.5197 Epstein, 2001, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, 107, 43, 10.1016/S0092-8674(01)00507-4 Ivan, 2001, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817 Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796 Bruick, 2001, A conserved family of prolyl-4-hydroxylases that modify HIF, Science, 294, 1337, 10.1126/science.1066373 Schofield, 1999, Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes, Curr. Opin. Struct. Biol., 9, 722, 10.1016/S0959-440X(99)00036-6 Iwai, 1999, Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex, Proc. Natl. Acad. Sci. U. S. A., 96, 12436, 10.1073/pnas.96.22.12436 Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459 Elroy-Stein, 1998, Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system, 5.15.1 Samaniego, 1994, Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2, J. Biol. Chem., 269, 30904, 10.1016/S0021-9258(18)47367-X Ohh, 2000, Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel–Lindau protein, Nat. Cell Biol., 2, 423, 10.1038/35017054 Yamanaka, 2003, Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2, Nat. Cell Biol., 5, 336, 10.1038/ncb952 Cockman, 2000, Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel–Lindau tumor suppressor protein, J. Biol. Chem., 275, 25733, 10.1074/jbc.M002740200